Unknown

Dataset Information

0

Azetidines Kill Multidrug-Resistant Mycobacterium tuberculosis without Detectable Resistance by Blocking Mycolate Assembly.


ABSTRACT: Tuberculosis (TB) is the leading cause of global morbidity and mortality resulting from infectious disease, with over 10.6 million new cases and 1.4 million deaths in 2021. This global emergency is exacerbated by the emergence of multidrug-resistant MDR-TB and extensively drug-resistant XDR-TB; therefore, new drugs and new drug targets are urgently required. From a whole cell phenotypic screen, a series of azetidines derivatives termed BGAz, which elicit potent bactericidal activity with MIC99 values <10 μM against drug-sensitive Mycobacterium tuberculosis and MDR-TB, were identified. These compounds demonstrate no detectable drug resistance. The mode of action and target deconvolution studies suggest that these compounds inhibit mycobacterial growth by interfering with cell envelope biogenesis, specifically late-stage mycolic acid biosynthesis. Transcriptomic analysis demonstrates that the BGAz compounds tested display a mode of action distinct from the existing mycobacterial cell wall inhibitors. In addition, the compounds tested exhibit toxicological and PK/PD profiles that pave the way for their development as antitubercular chemotherapies.

SUBMITTER: Cui Y 

PROVIDER: S-EPMC10895678 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Azetidines Kill Multidrug-Resistant <i>Mycobacterium tuberculosis</i> without Detectable Resistance by Blocking Mycolate Assembly.

Cui Yixin Y   Lanne Alice A   Peng Xudan X   Browne Edward E   Bhatt Apoorva A   Coltman Nicholas J NJ   Craven Philip P   Cox Liam R LR   Cundy Nicholas J NJ   Dale Katie K   Feula Antonio A   Frampton Jon J   Fung Martin M   Morton Michael M   Goff Aaron A   Salih Mariwan M   Lang Xingfen X   Li Xingjian X   Moon Chris C   Pascoe Jordan J   Portman Vanessa V   Press Cara C   Schulz-Utermoehl Timothy T   Lee Suki S   Tortorella Micky D MD   Tu Zhengchao Z   Underwood Zoe E ZE   Wang Changwei C   Yoshizawa Akina A   Zhang Tianyu T   Waddell Simon J SJ   Bacon Joanna J   Alderwick Luke L   Fossey John S JS   Neagoie Cleopatra C  

Journal of medicinal chemistry 20240208 4


Tuberculosis (TB) is the leading cause of global morbidity and mortality resulting from infectious disease, with over 10.6 million new cases and 1.4 million deaths in 2021. This global emergency is exacerbated by the emergence of multidrug-resistant MDR-TB and extensively drug-resistant XDR-TB; therefore, new drugs and new drug targets are urgently required. From a whole cell phenotypic screen, a series of azetidines derivatives termed BGAz, which elicit potent bactericidal activity with MIC<sub  ...[more]

Similar Datasets

| S-EPMC3128490 | biostudies-literature
| S-EPMC3553693 | biostudies-literature
2009-03-19 | E-BUGS-80 | biostudies-arrayexpress
| S-EPMC11243650 | biostudies-literature
| S-EPMC8348819 | biostudies-literature
| S-EPMC9033802 | biostudies-literature
| S-EPMC11790485 | biostudies-literature
| S-EPMC6738904 | biostudies-literature
| S-EPMC3710825 | biostudies-other
| S-EPMC10956945 | biostudies-literature